Salta al contenuto principale

Oncology

Modular nanotechnological platform, able to improve the biodistribution and bioavailability of a combination of drugs

Chimeric complex characterized by a high anti-metastatic activity for the treatments of solid tumors. 

Molecule for the treatment of solid tumors characterized by metastatic activity

New diagnostic test for Philadelphia chromosome negative myeloproliferative neoplasms

High sensitive diagnostic kit for the evaluation of the two most frequent mutations of the IDH2 gene in patients with acute myeloid leukemia and myelodysplasia

DNA vaccine for use in the prophylactic or therapeutic treatment of pancreatic ductal adenocarcinoma

Innovative molecular approach to reverse resistance to chemotherapy and reduce its toxicity

Cancer vaccine to increase the anti-tumor immune response in the percentage of patients affected by tumors that express CSPG4

The proposed technology consists of a molecular that allow to predictively identify which colorectal cancer patients could benefit from specific type of treatment

Urinary biomarkers for the diagnosis and follow-up of prostate cancer

Strategy for the treatment of tumors, based on blocking the "heme synthesis-export" system

Nanoconstruct and ultrasound activation set-up able to treat tumor cell and induce them to death with no need of chemotherapeutic drugs

Non-invasive screening method for bladder cancer based on biomarkers found in urine